Proactive Investors - Run By Investors For Investors

Pressure BioSciences showcases abilities of Ultra Shear Technology platform to improve CBD oil

This new form of CBD oil improves the effectiveness of CBD dosing as well as absorption
test tubes
Pressure BioSciences provides high pressure-based scientific instruments for drug design and development and food science

Pressure BioSciences Inc (OTCMKTS:PBIO) on Tuesday unveiled a video which showcases the ability of its Ultra Shear Technology platform to create water-soluble CBD (cannabidiol) oil that disperses instantly.

This new form of CBD oil improves the effectiveness of CBD dosing as well as absorption and makes it easier for the oil to be added to sodas and seltzers, vitamin-infused sports drinks and beer.

 

 

“After reviewing available data and PBI’s videos, we believe methods like PBI’s UST platform may enable us to offer products with superior quality and effectiveness,” said Edgar Ward, CEO of Nutralife Biosciences, which sells a line of CBD-infused products.

CBD is a non-psychoactive compound extracted from the cannabis plant which offers health benefits ranging from stress and anxiety relief to decreased muscle, joint, cancer and other pain.

Headquartered in South Easton, Massachusetts, Pressure BioSciences provides high pressure-based scientific instruments for biomarker discovery, drug design and development, food science, forensics and counter-bioterror applications.

Pressure BioSciences shares were trading at $3.01 in morning trade Tuesday.

Contact Ellen Kelleher at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full PBIO profile View Profile

Pressure BioSciences Inc. Timeline

Related Articles

test tubes
May 07 2019
Here we take a closer look at Arix Biosciences PLC (LON:ARIX), a listed venture capital company that doesn’t appear to be receiving the recognition it deserves
Nemaura Medical Inc CEO Dr Faz Chowdhury
November 05 2018
The medtech company is eying explosive growth with sugarBEAT, on the cusp of launching in the UK, followed by the rest of Europe in 2018
Weight loss
January 07 2019
A deal with Indian firm Zeon Lifesciences in January is the ninth deal the firm has secured for the weight loss product
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use